Home » Stocks » HUGE

FSD Pharma Inc. (HUGE)

Stock Price: $1.94 USD -0.27 (-12.22%)
Updated Jan 27, 2021 4:00 PM EST - Market closed
Pre-market: $2.00 +0.06 (3.09%) Jan 28, 6:46 AM
Market Cap 36.31M
Revenue (ttm) 196,259
Net Income (ttm) -39.70M
Shares Out 7.06M
EPS (ttm) -5.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 27
Last Price $1.94
Previous Close $2.21
Change ($) -0.27
Change (%) -12.22%
Day's Open 2.02
Day's Range 1.78 - 2.02
Day's Volume 1,443,859
52-Week Range 1.36 - 7.39

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 1 day ago

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announces the following corporate updates. Corporate Update The Company continues to ...

Business Wire - 5 days ago

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (“FSD Pharma” or the “Company”) today announced that it will hold its annual meeting of shareholders (the “Meeting”) on June ...

Business Wire - 1 month ago

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announced the dosing of the first patient in its Phase 2a clinical trial of FSD201 (u...

Schaeffers Research - 2 months ago

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and we will look ahead at the pot stocks to w...

Other stocks mentioned: ACB, ARNA, CGC, HEXO, KERN, OGI, SNDL, TLRY, VFF, YCBD, ZYNE
Business Wire - 2 months ago

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announced its financial results for the third quarter ending September 30, 2020 and p...

Business Wire - 2 months ago

TORONTO--(BUSINESS WIRE)-- #FSDPharma--FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) ("FSD Pharma" or the "Company") today announced that, subject to court certification and other customary conditi...

Business Wire - 3 months ago

TORONTO--(BUSINESS WIRE)-- #HUGE--FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced the closing of previously announced definitive agreements with investors for t...

Business Wire - 3 months ago

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced that it has entered into definitive agreements with investors for the purchas...

Business Wire - 3 months ago

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) announced that the U.S. Food and Drug Administration (“FDA”) has authorized the...

Business Wire - 4 months ago

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) today announced that it has submitted to the U.S.

Business Wire - 5 months ago

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today reported that management’s discussion and analysis of financi...

Business Wire - 5 months ago

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) announces the closing of a previously announced agreement with investors for th...

Newsfile Corp - 5 months ago

Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - FSD Pharma Inc.

Business Wire - 5 months ago

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”), today announced that it has entered into definitive agreements with investors ...

Business Wire - 5 months ago

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced that it has notified Health Canada of the Company’s...

Business Wire - 6 months ago

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) today announced that it has entered into an Equity Distribution Agreement dated...

Newsfile Corp - 7 months ago

Vancouver, British Columbia--(Newsfile Corp. - June 23, 2020) -  FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9), a specialty, biotech pharmaceutical R&D company, focused on developing,...

Business Wire - 7 months ago

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the "Company") today announced favorable topline results from its Phase 1 randomiz...

Seeking Alpha - 7 months ago

FSD Pharma Jumps On COVID-19 Trial Progress, And Other News: The Good, Bad And Ugly Of Biopharma

Investors Business Daily - 7 months ago

Shares of FSD Pharma tripled Wednesday after the small-cap biotech company announced plans to study a potential coronavirus treatment. The drug is called ultramicronized PEA.

24/7 Wall Street - 7 months ago

FSD Pharma Inc. (NASDAQ: HUGE) shares absolutely exploded on Wednesday morning after the company received a key update from the U.S.

Benzinga - 7 months ago

Shares of FSD Pharma Inc (NASDAQ: HUGE) are advancing strongly Wednesday following an announcement regarding a potential COVID-19 drug.

Benzinga - 11 months ago

FSD Pharma Inc (NASDAQ: HUGE) has netted itself more than $7.7 million through the sale of its 12% equity interest in Cannara Biotech Inc (OTC: LOVFF) to a consortium of that included entities...

Benzinga - 1 year ago

FSD Pharma Inc (CSE: HUGE) (OTC: FSDDF) said Monday that its Class B Subordinate Voting Shares have been accepted for listing on the NASDAQ Capital Market under the ticker "HUGE.

Other stocks mentioned: FSDDF
Benzinga - 1 year ago

FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) said Monday it has obtained approval for its Class B subordinate shares to list on the Nasdaq Capital Market.

Other stocks mentioned: FSDDF

About HUGE

FSD Pharma, through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is ... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
Founded
1998
CEO
Raza Bokhari
Employees
17
Stock Exchange
NASDAQ
Ticker Symbol
HUGE
Full Company Profile

Financial Performance

Financial numbers in millions CAD.
Financial Statements